Compounded bulk powder
• Not FDA approved
• Subtherapeutic, poor absorption in 98%
Generic and brand name Sporanox comparable
• FDA approved
• Subtherapeutic in 22 to 24%
• Therapeutic 43 to 55%
• Potentially toxic in 18 to 35%
TEST CODE: 312
TURNAROUND: Testing is performed on Wednesdays. Results are released the next morning.
LIMITATIONS: Results are not intended to be used asthe sole means for clinical diagnosis or patientmanagement decisions.
CLINICAL SIGNIFICANCE: Monitors blood itraconazole concentrations in animals during antifungal drug treatment to determine therapeutic levels.
SPECIMEN REQUIREMENTS: Serum or Plasma ONLY. Any other type of specimen will be rejected.
SPECIMEN MINIMUM: 0.25 ml Serum/ Plasma
COLLECTION INSTRUCTIONS: Refrigerated/Frozen
SPECIMEN STABILITY: 7 Days Room Temperature/Refrigerated/Frozen
TRANSPORT TEMPERATURE: Refrigerated/Frozen
SHIPPING INSTRUCTIONS: Ship refrigerated/frozen specimen on dry ice or frozen cool pack for Next Day Delivery Monday – Friday.
(1) Renschler, J., et al., Comparison of Compounded, Generic, and Innovator-Formulated Itraconazole in Dogs and Cats. J Am Anim Hosp Assoc, 2018. 54(4): p. 195-200.